Business Description
HAVN Life Sciences Inc
NAICS : 541714
SIC : 3741
ISIN : CA4196213058
Share Class Description:
XCNQ:HAVN: Ordinary SharesCompare
Compare
Traded in other countries / regions
HAVN.CanadaHAVLF.USA5NP0.Germany IPO Date
2020-09-08Description
HAVN Life Sciences Inc is a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs, the development of natural health products, and innovative therapies to support brain health and enhance the capabilities of the mind. Through its research division, HAVN Labs, the company has developed an end-to-end supply chain of standardized, naturally derived psychedelic compounds for research that will define the future of modern medicine. With its new line of natural health products, it offers a full range of high-quality mushroom and plant extracts that help boost immune function, reduce inflammation and support a healthy lifestyle.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -444.63 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
HAVN Life Sciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 0.587 | ||
| EPS (TTM) (C$) | -30.041 | ||
| Beta | -0.72 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0 | ||
| 20-Day SMA (C$) | 0.03 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.03 - 0.03 | ||
| Shares Outstanding (Mil) | 14.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
HAVN Life Sciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
HAVN Life Sciences Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
HAVN Life Sciences Inc Frequently Asked Questions
What is HAVN Life Sciences Inc(XCNQ:HAVN)'s stock price today?
The current price of XCNQ:HAVN is C$0.03. The 52 week high of XCNQ:HAVN is C$0.03 and 52 week low is C$0.03.
When is next earnings date of HAVN Life Sciences Inc(XCNQ:HAVN)?
The next earnings date of HAVN Life Sciences Inc(XCNQ:HAVN) is 2024-12-31 Est..
Does HAVN Life Sciences Inc(XCNQ:HAVN) pay dividends? If so, how much?
HAVN Life Sciences Inc(XCNQ:HAVN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers